Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Sea Otter who wrote (354)	3/10/1999 10:28:00 AM
From: QuietWon	Respond to of 2515

Earliest indications I'm guessing would be known to the company about a couple of months after a patient is injected with the drug. Don't know when patients are injected (I doubt they'll inject everybody on the same day), but my guess is when they have some reasonable amount of patients' results that they would say something (at least I hope they give some kind of idea how things are going). We will know certainly within a year, since they said the trial is to last one year. IMCL has been conservative, imo, in their announcements and met the timings they've indicated in their PR's. My best guess is this is a good 3-6 month hold and very likely a hold beyond that period. You can trade it if you wish, but it's a good hold, imo